In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.
Science on heart failure

Watch on-demand webinars on Late-Breaking Trials, and explore clinical cases, important HFA position papers, and more.

 

Access now

European Journal of Heart Failure

Advancing knowledge in the field of heart failure management

 

The European Journal of Heart Failure (EJHF) is dedicated to the advancement of knowledge in the field of heart failure management.

The journal publishes reviews and editorials to improve the understanding, prevention, investigation and treatment of heart failure. Molecular and cellular biology, pathology, physiology, electrophysiology, pharmacology, as well as clinical, social and population sciences all form part of the discipline.

Submit your paper

Fast Facts

  • Editor-in-chief: Marco Metra (IT)
  • Current volume: 25 (year 2023)
  • Issues per subscription: 12
  • Impact Factor 2021:  18.174

 

Editor-in-chief History

 

Name Start Date End Date
Professor John Cleland 01/01/1999 31/12/2004
Professor Karl Swedberg 01/01/2005 31/12/2009
Professor Dirk J. Van Veldhuisen 01/01/2010 31/12/2014
Professor Marco Metra 01/01/2015  
Updates on latest articles

Updates on latest articles

 

Receive the table of contents in your mailbox.

Track topics and authors important to you and receive articles in your mailbox.

For Authors

Before being published, all manuscripts go through double-blind peer review by experienced international experts.


Most recent articles from EJHF

08 Feb 2023
Acute heart failure after non‐cardiac surgery: incidence, phenotypes, determinants and outcomes
Author(s): Danielle M. Gualandro, Christian Puelacher, Michelle S. Chew, Henrik Andersson, Giovanna Lurati Buse, Noemi Glarner, Daria Mueller, Francisco A.M. Cardozo, Katrin Burri‐Winkler, Constantin Mork, Desiree Wussler, Samyut Shrestha, Isabelle Heidelberger, Mikael Fält, Reka Hidvegi, Daniel Bolliger, Andreas Lampart, Luzius A. Steiner, Stefan Schären, Christoph Kindler, Lorenz Gürke, Daniel Rikli, Didier Lardinois, Stefan Osswald, Andreas Buser, Bruno Caramelli, Christian Mueller, for the BASEL‐PMI Investigators
07 Feb 2023
Effect of patisiran on stroke volume in hereditary transthyretin‐mediated amyloidosis: insights from pressure–volume analysis of the APOLLO study
Author(s): Hannah R. Rosenblum, Jan M. Griffin, Masatoshi Minamisawa, Narayana Prasad, John Vest, Matthew T. White, Scott D. Solomon, Daniel Burkhoff, Mathew S. Maurer
07 Feb 2023
Interleukin‐6 in acute heart failure: it does work, but how much? Letter regarding the article ‘Quantifying inflammation using interleukin‐6 for improved phenotyping and risk stratification in acute heart failure’
Author(s): Sibo Wang, Jiateng Sun, Liansheng Wang
07 Feb 2023
Letter regarding the article ‘Little at a time: trying to understand the battery of benefits of sodium–glucose cotransporter 2 inhibitors in heart failure’
Author(s): Camilla Fuchs Andersen, Andreas Glenthøj, Jesper Jensen